New Roles for the LKB1-NUAK Pathway in Controlling Myosin Phosphatase Complexes and Cell Adhesion
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
The kinase NUAK1, which is linked to tumor invasion, promotes cell detachment by activating cytoskeletal motor proteins.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“NUAK1 directly binds to and activates the PP1B phosphatase by displacing the self-inhibitory protein I-248.”
From LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers (2025) · cites this paper as [48]
In the citing paper
“NUAKs regulate cell polarity46, ploidy47, and adhesion48 through phosphorylation of the myosin phosphatase targeting-1-protein phosphatase-1beta (PP1B) complex.”
From LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers (2025) · cites this paper as [48]
In the citing paper
“NUAK kinases have been shown to regulate cellular polarity, adhesion, and cell cycle in normal tissues46,48,71 and to play a critical role in neurite formation72.”
From LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers (2025) · cites this paper as [48]
Citations
Cites
AMPK Phosphorylation of Raptor Mediates a Metabolic Checkpoint
Gwinn, D. M., Shackelford, D. B., Egan, D. F., Mihaylova, M. M., Mery, A., Vasquez, D. S., Turk, B. E., & Shaw, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.003 · Cited by 3,849 · cited 3×
“Furthermore, Ser(445), Ser(472), and Ser(910) lie in favorable AMPK family phosphorylation motifs, with conserved hydrophobic amino acids at the −5 and +4 positions and an Arg or Lys residue at the −3 position from the phosphorylation site (33, 34) (fig.”
BackgroundPatterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
Non-muscle myosin II takes centre stage in cell adhesion and migration
Vicente-Manzanares, M., Ma, X., Adelstein, R. S., & Horwitz, A. R. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2786 · Cited by 2,032 · cited 9×
“MYPT1 total MYPT1 pS910 MYPT1 pS472 MYPT1 pS445 NUAK1 A B C - PB S Try ps inED TA ED TA bu ffe r 1 m M ED TA in PB S 10 m M ED TA in PB S Me ch an ica l - + - + MEF EDTA buffer MYPT1 total MYPT1 pS910 MYPT1 pS472 MYPT1 pS445 NUAK1 HeLa stably overexpressing Empty vector LKB1 wt LKB1 ki - + - + - +EDTA buffer MYPT1 tot…”
BackgroundInfluentialThe LKB1-AMPK pathway: metabolism and growth control in tumour suppression
Shackelford, D. B., & Shaw, R. J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2676 · Cited by 1,943 · cited 8×
“MYPT1 total MYPT1 pS910 MYPT1 pS472 MYPT1 pS445 NUAK1 A B C - PB S Try ps inED TA ED TA bu ffe r 1 m M ED TA in PB S 10 m M ED TA in PB S Me ch an ica l - + - + MEF EDTA buffer MYPT1 total MYPT1 pS910 MYPT1 pS472 MYPT1 pS445 NUAK1 HeLa stably overexpressing Empty vector LKB1 wt LKB1 ki - + - + - +EDTA buffer MYPT1 tot…”
BackgroundInfluentialA serine/threonine kinase gene defective in Peutz–Jeghers syndrome
Hemminki, A., Markie, D., Tomlinson, I., Avizienyte, E., Roth, S., Loukola, A., Bignell, G., Warren, W., Aminoff, M., Höglund, P., et al. (1998) · Nature · doi:10.1038/34432 · Cited by 1,656 · cited 8×
“MYPT1 total MYPT1 pS910 MYPT1 pS472 MYPT1 pS445 NUAK1 A B C - PB S Try ps inED TA ED TA bu ffe r 1 m M ED TA in PB S 10 m M ED TA in PB S Me ch an ica l - + - + MEF EDTA buffer MYPT1 total MYPT1 pS910 MYPT1 pS472 MYPT1 pS445 NUAK1 HeLa stably overexpressing Empty vector LKB1 wt LKB1 ki - + - + - +EDTA buffer MYPT1 tot…”
BackgroundInfluentialLKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR‐1
Lizcano, J. M., Göransson, O., Toth, R., Deak, M., Morrice, N. A., Boudeau, J., Hawley, S. A., Udd, L., Mäkelä, T. P., Hardie, D. G., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600110 · Cited by 1,381
Self-citationGuo, S., & Kemphues, K. J. (1995) · Cell · doi:10.1016/0092-8674(95)90082-9 · Cited by 1,122
LKB1-Dependent Signaling Pathways
Alessi, D. R., Sakamoto, K., & Bayascas, J. R. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142702 · Cited by 788
Self-citationCrosstalk of tight junction components with signaling pathways
González-Mariscal, L., Tapia, R., & Chamorro, D. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.08.018 · Cited by 759 · cited 8×
“MYPT1 total MYPT1 pS910 MYPT1 pS472 MYPT1 pS445 NUAK1 A B C - PB S Try ps inED TA ED TA bu ffe r 1 m M ED TA in PB S 10 m M ED TA in PB S Me ch an ica l - + - + MEF EDTA buffer MYPT1 total MYPT1 pS910 MYPT1 pS472 MYPT1 pS445 NUAK1 HeLa stably overexpressing Empty vector LKB1 wt LKB1 ki - + - + - +EDTA buffer MYPT1 tot…”
BackgroundInfluentialThe CREB Coactivator TORC2 Functions as a Calcium- and cAMP-Sensitive Coincidence Detector
Screaton, R. A., Conkright, M. D., Katoh, Y., Best, J. L., Canettieri, G., Jeffries, S., Guzman, E., Niessen, S., Yates, J. R., Takemori, H., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.015 · Cited by 648 · cited 9×
“MYPT1 total MYPT1 pS910 MYPT1 pS472 MYPT1 pS445 NUAK1 A B C - PB S Try ps inED TA ED TA bu ffe r 1 m M ED TA in PB S 10 m M ED TA in PB S Me ch an ica l - + - + MEF EDTA buffer MYPT1 total MYPT1 pS910 MYPT1 pS472 MYPT1 pS445 NUAK1 HeLa stably overexpressing Empty vector LKB1 wt LKB1 ki - + - + - +EDTA buffer MYPT1 tot…”
BackgroundInfluential
Cited by
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Mihaylova, M. M., & Shaw, R. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2329 · Cited by 2,923
“The recent discovery of AMPK family members controlling phosphatase”
Actin stress fibers – assembly, dynamics and biological roles
Tojkander, S., Gateva, G., & Lappalainen, P. (2012) · Journal of Cell Science · doi:10.1242/jcs.098087 · Cited by 900
AMP-activated protein kinase: new regulation, new roles?
Carling, D., Thornton, C., Woods, A., & Sanders, M. J. (2012) · Biochemical Journal · doi:10.1042/bj20120546 · Cited by 379
Courchet, J., Lewis, T. L., Lee, S., Courchet, V., Liou, D.-Y., Aizawa, S., & Polleux, F. (2013) · Cell · doi:10.1016/j.cell.2013.05.021 · Cited by 349
“NUAK1 kinase activity was assessed as described elsewhere (Zagórska et al., 2010) with minor modification.”
Self-citationProtein kinase signaling networks in cancer
Brognard, J., & Hunter, T. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2010.10.012 · Cited by 240
“This activation leads to the phosphorylation of MYPT1 (myosin light chain phosphatase 1) and subsequent suppression of its phosphatase activity by binding to 14-3-3, ultimately leading to increased MLC2 phosphorylation [65 ].”
Grassie, M. E., Moffat, L. D., Walsh, M. P., & MacDonald, J. A. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.01.018 · Cited by 236
Distinct roles for ROCK1 and ROCK2 in the regulation of cell detachment
Shi, J., Wu, X., Surma, M., Vemula, S., Zhang, L., Yang, Y., Kapur, R., & Wei, L. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.10 · Cited by 231
“Excessive myosin activity may destabilize central stress fibers.(31,32) We observed that doxorubicin treatment induced an increase in MLC2 phosphorylation, which could be detected within 30 min in WT MEFs (Figure 3c).”
BackgroundYAP and TAZ limit cytoskeletal and focal adhesion maturation to enable persistent cell motility
Mason, D. E., Collins, J. M., Dawahare, J. H., Nguyen, T. D., Lin, Y., Voytik-Harbin, S. L., Zorlutuna, P., Yoder, M. C., & Boerckel, J. D. (2019) · Journal of Cell Biology · doi:10.1083/jcb.201806065 · Cited by 193
Arabidopsis PPP family of serine/threonine protein phosphatases: many targets but few engines
Uhrig, R. G., Labandera, A.-M., & Moorhead, G. B. (2013) · Trends in Plant Science · doi:10.1016/j.tplants.2013.05.004 · Cited by 184
Yang, C., Zhang, Y., Lin, S., Liu, Y., & Li, W. (2021) · Aging · doi:10.18632/aging.202774 · Cited by 174
“WB results (Figure 3B) indicated that, KIF20A silencing inhibited the activation of intracellular NUAK1 (expressed as the phosphorylation level of MYPT1 S445 ), but there was no effect on NUAK1 expression level [23].”
Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1
Najafov, A., Sommer, E. M., Axten, J. M., DeYoung, M. P., & Alessi, D. R. (2010) · Biochemical Journal · doi:10.1042/bj20101732 · Cited by 160
Self-citationMO25 is a master regulator of SPAK/OSR1 and MST3/MST4/YSK1 protein kinases
Filippi, B., Heros, P. D. L., Mehellou, Y., Navratilova, I. H., Gourlay, R., Deák, M., Plater, L., Toth, R. L., Zeqiraj, E., & Alessi, D. R. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.78 · Cited by 148
Self-citationBile acid stimulates hepatocyte polarization through a cAMP-Epac-MEK-LKB1-AMPK pathway
Fu, D., Wakabayashi, Y., Lippincott-Schwartz, J., & Arias, I. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018376108 · Cited by 140
“Polarity effects of LKB1 have also been associated with PAR proteins, AMPK-related kinases NUAK1/2, which are activated by LKB1, and control of cell adhesion by regulating myosin phosphatase complexes (49).”
BackgroundWu, Y., Ali, M. R. K., Dong, B., Han, T., Chen, K., Chen, J., Tang, Y., Fang, N., Wang, F., & El‐Sayed, M. A. (2018) · ACS Nano · doi:10.1021/acsnano.8b04128 · Cited by 140
Lin, C., Yao, E., Zhang, K., Jiang, X., Croll, S., Thompson-Peer, K. L., & Chuang, P. (2017) · eLife · doi:10.7554/elife.21130 · Cited by 138
NUAK2 is a critical YAP target in liver cancer
Yuan, W.-C., Pepe-Mooney, B., Galli, G. G., Dill, M. T., Huang, H.-T., Hao, M., Wang, Y., Liang, H., Calogero, R. A., & Camargo, F. D. (2018) · Nature Communications · doi:10.1038/s41467-018-07394-5 · Cited by 128
Transcription Factor/microRNA Axis Blocks Melanoma Invasion Program by miR-211 Targeting NUAK1
Bell, R. E., Khaled, M., Netanely, D., Schubert, S., Golan, T., Buxbaum, A., Janas, M. M., Postolsky, B., Goldberg, M. S., Shamir, R., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.340 · Cited by 131
“BX795, is a potent protein kinase inhibitor that has been shown to inhibit the PDK1/Akt pathway (Feldman et al., 2005), TBK1 and IKKepsilon (Clark et al., 2009), and the LKB1/NUAK1 pathway (Zagorska et al., 2010).”
BackgroundInfluentialRodriguez-Fraticelli, A., Auzan, M., Alonso, M. A., Bornens, M., & Martín‐Belmonte, F. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201203075 · Cited by 124
“LKB1 control of myosin II activity through RLC2 phosphorylation has been previously described, although there is some controversy as to how this effect is directly mediated downstream of LKB1 (Mirouse et al., 2007; Zagórska et al., 2010; Chartier et al., 2011).”
Par-1 Controls Myosin-II Activity through Myosin Phosphatase to Regulate Border Cell Migration
Majumder, P., Aranjuez, G. F., Amick, J., & McDonald, J. A. (2012) · Current Biology · doi:10.1016/j.cub.2012.01.037 · Cited by 112
“Notably, vertebrate MARK2 (Par-1) phosphorylates the Mbs homolog MYPT1 in vitro at several sites, including the conserved threonine examined here [31], although this has not been confirmed in vivo.”
An LKB1–SIK Axis Suppresses Lung Tumor Growth and Controls Differentiation
Murray, C. W., Brady, J. J., Tsai, M. K., Li, C., Winters, I. P., Tang, R., Andrejka, L., Ma, R. K., Kunder, C. A., Chu, P., et al. (2019) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-1237 · Cited by 111
“Beyond its role in cancer, Lkb1 also influences a broad range of normal processes (10-15,66,67).”
BackgroundWalkinshaw, D. R., Weist, R., Kim, G.-W., You, L., Xiao, L., Nie, J., Li, C. S., Zhao, S., Xu, M., & Yang, X.-J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.456996 · Cited by 97
“associated protein/microtubule affinity-regulation kinases (MARK) (34, 79, 80) and controls cell senescence (81) and adhesion (82) via NUAK1.”
BackgroundColorectal Tumors Require NUAK1 for Protection from Oxidative Stress
Port, J., Muthalagu, N., Raja, M., Ceteci, F., Monteverde, T., Kruspig, B., Hedley, A., Kalna, G., Lilla, S., Neilson, L., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0533 · Cited by 93
“Notably, phosphorylation of MYPT1 by NUAK1 inhibits PP1β activity (10), and PP1β was previously shown to dephosphorylate GSK3β (32, 33).”
BackgroundMyosin phosphatase: Unexpected functions of a long-known enzyme
Kiss, A., Erdődi, F., & Lontay, B. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.07.023 · Cited by 103
Evidence of cancer‐promoting roles for AMPK and related kinases
Monteverde, T., Muthalagu, N., Port, J., & Murphy, D. J. (2015) · FEBS Journal · doi:10.1111/febs.13534 · Cited by 100
“NUAK1 was mechanistically linked to cell detachment via direct phosphorylation of the myosin phosphatase complex subunit MYPT1, supporting a role for NUAK1 in facilitating cell motility [58].”
BackgroundBanerjee, S., Buhrlage, S. J., Huang, H.-T., Deng, X., Zhou, W., Wang, J., Traynor, R., Prescott, A. R., Alessi, D. R., & Gray, N. S. (2014) · Biochemical Journal · doi:10.1042/bj20131152 · Cited by 84
“It is likely that both NUAK1 and NUAK2 isoforms phosphorylate MYPT1 at Ser 445 and that the residual phosphorylation of MYPT1 observed in NUAK1-knockout MEFs is mediated by NUAK2 [10].”
InfluentialSelf-citationMolecular mechanisms of tumor suppression by LKB1
Vaahtomeri, K., & Mäkelä, T. P. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.12.034 · Cited by 87
“creased phosphorylation of MLC, which is controlled in part by NUAK kinases [120,125], and subsequently enhanced cell contrac-”
BackgroundThe tumor suppressor kinase LKB1: lessons from mouse models
Ollila, S., & Mäkelä, T. P. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjr016 · Cited by 87
“As formation of stress fibers is essential in cell contractility, recent studies associate LKB1 with cell motility via NUAK1 and NUAK2, which have been implicated in regulation of myosin light chain phosphorylation (Vallenius et al., 2010; Zagorska et al., 2010).”
BackgroundSundararaman, A., Amirtham, U., & Rangarajan, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.731257 · Cited by 86
“Because serine proteases such as trypsin are known to increase calcium levels independent of detachment (39), we have used mechanical detachment by cell scraping (19, 21, 22) instead of routine trypsinization for understanding the effects of cell detachment on the kinetics of calcium and its role in rapid AMPK activat…”
BackgroundMethodInfluentialAngulo‐Urarte, A., Casado, P., Castillo, S. D., Kobialka, P., Kotini, M. P., Figueiredo, A. M., Castel, P., Rajeeve, V., Milà‐Guasch, M., Millán, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07172-3 · Cited by 84
Cancer-Associated Loss-of-Function Mutations Implicate DAPK3 as a Tumor-Suppressing Kinase
Brognard, J., Zhang, Y.-W., Puto, L. A., & Hunter, T. R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3543 · Cited by 83
Roy, I., McAllister, D. M., Gorse, E., Dixon, K., Piper, C. T., Zimmerman, N. P., Getschman, A. E., Tsai, S., Engle, D. D., Evans, D. B., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2645 · Cited by 74
LKB1 Regulated Pathways in Lung Cancer Invasion and Metastasis
Marcus, A. I., & Zhou, W. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181fbc28a · Cited by 80
“Thus, when taken in combination with the increased adhesion observed in LKB1 mutant cells 37 , 40 , LKB1 loss could provide cells not only the ability to adhere to the ECM during invasion but also the ability to survive when unattached.”
BackgroundThe LKB1/AMPK polarity pathway
Mirouse, V., & Billaud, M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.12.025 · Cited by 67
“One member of the ARKs, NUAK1, phosphorylates and inactivates one of the regulatory subunits of the myosin phosphatase, thus suggesting that AMPK could perform a similar type of regulation [24].”
BackgroundMechanisms linking mechanotransduction and cell metabolism
Salvi, A. M., & DeMali, K. A. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2018.05.004 · Cited by 79
“An AMPK-related kinase, known as NUAK1, phosphorylates and inactivates the myosin phosphatase, suggesting that AMPK could perform a similar type of regulation [37].”
BackgroundLkb1 Is Indispensable for Skeletal Muscle Development, Regeneration, and Satellite Cell Homeostasis
Shan, T., Zhang, P., Liang, X., Bi, P., Yue, F., & Kuang, S. (2014) · Stem Cells · doi:10.1002/stem.1788 · Cited by 69
Namiki, T., Tanemura, A., Valencia, J. C., Coelho, S. G., Passeron, T., Kawaguchi, M., Vieira, W. D., Ishikawa, M., Nishijima, W., Izumo, T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007694108 · Cited by 61
“Recent studies revealed that NUAK2 participates in cell detachment by regulating the phosphorylation of MLC2 through MYPT1, which is a specific substrate for NUAK2 (23, 33).”
BackgroundThe AMPK-related kinase SIK2 is regulated by cAMP via phosphorylation at Ser358 in adipocytes
Henriksson, E., Jones, H. A., Patel, K., Peggie, M. W., Morrice, N. A., Sakamoto, K., & Göransson, O. (2012) · Biochemical Journal · doi:10.1042/bj20111932 · Cited by 75
Targeting the LKB1 Tumor Suppressor
Zhao, R., & Xu, Z. (2014) · Current Drug Targets · doi:10.2174/1389450114666140106095811 · Cited by 70
Effects of environmentally relevant metformin exposure on Japanese medaka (Oryzias latipes)
Ussery, E. J., Bridges, K. N., Pandelides, Z., Kirkwood, A. E., Bonetta, D. T., Venables, B. J., Guchardi, J., & Holdway, D. A. (2018) · Aquatic Toxicology · doi:10.1016/j.aquatox.2018.10.003 · Cited by 71
Dzeja, P. P., Chung, S. S., Faustino, R. S., Behfar, A., & Terzic, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019300 · Cited by 70
“Moreover, signaling through AMPK-family kinases activated by LKB1 regulates myosin phosphatases and cell adhesion [79], further implicating metabolic signaling circuits as common pathways in the etiology of multiple disease states [80].”
BackgroundEmerging roles of DYRK2 in cancer
Tandon, V., de la Vega, L., & Banerjee, S. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.015217 · Cited by 70
Self-citationCossa, G., Roeschert, I., Prinz, F., Baluapuri, A., Silveira Vidal, R., Schülein-Völk, C., Chang, Y.-C., Ade, C. P., Mastrobuoni, G., Girard, C., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.01.008 · Cited by 61
“In the trimer, NUAK1 phosphorylates MYPT1 and promotes association of MYPT1with 14-3-3 proteins (Zagórska et al., 2010).”
BackgroundInfluentialHughes, J. J., Alkhunaizi, E., Kruszka, P. S., Pyle, L. C., Grange, D. K., Berger, S., Payne, K. K., Masser‐Frye, D., Hu, T., Christie, M. R., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.12.004 · Cited by 65
“Current evidence does not support the possibility that PPP1R12A is part of the canonical pathways of HPE such as the hedgehog signaling pathways; however, PPP1R12A has an established role in cell migration, cell adhesion, and cytoskeletal organization.(30,31) Animal models, such as zebrafish morpholino knockdown of pp…”
BackgroundHoude, V. P., Ritorto, M. S., Gourlay, R., Varghese, J., Davies, P., Shpiro, N., Sakamoto, K., & Alessi, D. R. (2014) · Biochemical Journal · doi:10.1042/bj20131324 · Cited by 56
Self-citationChen, C., Chen, X., Qiao, Y., Wang, P., He, W., Zhang, C., Zhao, W. H., Gao, Y., Chen, C., Tao, T., et al. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.283853 · Cited by 63
“…kinases at multiple sites, including S432, S445, S472, S473, S601, S668, S692, S695, S852, S910, T696 and T853 (numbering based on human MYPT1) (Feng et al. 1999; Totsukawa et al. 1999; Wooldridge et al. 2004; Yamashiro et al. 2008; Zagorska et al. 2010; Yuen et al. 2011; Butler et al. 2013).”
A loss-of-function NUAK2 mutation in humans causes anencephaly due to impaired Hippo-YAP signaling
Bonnard, C., Navaratnam, N., Ghosh, K., Chan, P. W., Tan, T. T., Pomp, O., Ng, A. Y. J., Tohari, S., Changede, R., Carling, D., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191561 · Cited by 62
“This result is in line with previous observation that Nuak1−/− MEFs have significantly more F-actin stress fibers relative to WT counterparts (Zagórska et al., 2010).”
ResultLATS1/WARTS phosphorylates MYPT1 to counteract PLK1 and regulate mammalian mitotic progression
Chiyoda, T., Sugiyama, N., Shimizu, T., Naoe, H., Kobayashi, Y., Ishizawa, J., Arima, Y., Tsuda, H., Ito, M., Kaibuchi, K., et al. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201110110 · Cited by 60
“Phosphorylation of S445 within MYPT1 was still detected in mitotic arrested U2OS cells using an MYPT1 phospho-S445–specific antibody, possibly reflecting the existence of other S445 kinases, such as NUAK1 (Zagórska et al., 2010), but the phosphorylation level increased approximately twofold and peaked 20 min after ion…”
Vallenius, T., Vaahtomeri, K., Kovac, B., Osiceanu, A.-M., Viljanen, M., & Mäkelä, T. P. (2011) · Journal of Cell Science · doi:10.1242/jcs.072660 · Cited by 49
“Considering that phosphorylation of MYPT1 on Ser445 and Ser472 by NUAK1 leads to 14-3-3 binding (Zagorska et al., 2010), that phosphorylation of Ser472 was reported, in an independent study, to cause dissociation of MYPT1 from actin stress fibers (Koga and Ikebe, 2008) and also that complexes…”
BackgroundInfluentialHo, S. W. T., Sheng, T., Xing, M., Ooi, W. F., Xu, C., Sundar, R., Huang, K. K., Li, Z., Kumar, V., Ramnarayanan, K., et al. (2022) · Gut · doi:10.1136/gutjnl-2021-326483 · Cited by 56
Templeton, G. W., Nimick, M., Morrice, N. A., Campbell, D. G., Goudreault, M., Gingras, A., Takemiya, A., Shimazaki, K., & Moorhead, G. B. G. (2011) · Biochemical Journal · doi:10.1042/bj20101035 · Cited by 55
Self-citationLKB1 loss in melanoma disrupts directional migration toward extracellular matrix cues
Chan, K. T., Asokan, S. B., King, S. J., Bo, T., Dubose, E. S., Liu, W., Berginski, M. E., Simon, J. M., Davis, I. J., Gomez, S. M., et al. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201404067 · Cited by 54
“Given that the nua kinase (NUAK) family kinases are known to inhibit the activity of myosin phosphatase to control cell adhesion and are a promising candidate to regulate directional cell migration (Zagórska et al., 2010), we”
BackgroundNeural tube defects by NUAK1 and NUAK2 double mutation
Ohmura, T., Shioi, G., Hirano, M., & Aizawa, S. (2012) · Developmental Dynamics · doi:10.1002/dvdy.23816 · Cited by 54
“MLC2 phosphorylation must be regulated by many factors other than NUAK1 and NUAK2 during neurulation, and even in their absence the phosoprylation of MLC2 might be largely unchanged (Zagorska et al., 2010).”
BackgroundInfluentialSelf-citationCao, Z., Xiao, Q., Dai, X., Zhou, Z., Jiang, R., Cheng, Y., Yang, X., Guo, H., Wang, J., Xi, Z., et al. (2017) · Cell Death and Disease · doi:10.1038/s41419-017-0017-4 · Cited by 53
The Tumor Suppressor Kinase LKB1: Metabolic Nexus
Bourouh, M., & Marignani, P. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.881297 · Cited by 52
“NUAK 1 and 2 are also implicated in glucose tolerance and attenuation of insulin signaling in muscle cells and regulate cell motility and muscle contraction through activation of myosin (Koh et al., 2010; Zagórska et al., 2010; Vallenius et al., 2011).”
BackgroundInazuka, F., Sugiyama, N., Tomita, M., Abe, T., Shioi, G., & Esumi, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.302687 · Cited by 51
“The distribution of Nuak2 mRNA was also examined because NUAK1 and NUAK2 may have redundant functions (7, 30).”
BackgroundResultKonen, J. M., Wilkinson, S. C., Lee, B., Fu, H., Zhou, W., Jiang, Y., & Marcus, A. I. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-08-0569 · Cited by 49
“…including the microtubule affinity–regulating kinases (MARK1–4; Spicer et al ., 2003; Brajenovic et al ., 2004; Lizcano et al ., 2004), and NUAK1/2 (Zagórska et al ., 2010; Vallenius et al ., 2011) to control myosin contractility, SIK1 to oversee anoikis (Cheng et al ., 2009), and the…”
An Integrated Global Analysis of Compartmentalized HRAS Signaling
Santra, T., Herrero, A., Rodríguez, J., von Kriegsheim, A., Iglesias-Martinez, L. F., Schwarzl, T., Higgins, D. G., Aye, T., Heck, A. J. R., Calvo, F., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.038 · Cited by 49
“Similarly, PPP1R12A (MYPT1), a phosphatase that regulates myosin light chain kinase and smooth muscle contraction, was enriched in the ER-specific interactome but phosphorylated from the DM at an inhibitory site (Zagórska et al., 2010).”
Role of serine-threonine phosphoprotein phosphatases in smooth muscle contractility
Butler, T., Paul, J., Europe-Finner, N., Smith, R., & Chan, E.-C. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00161.2012 · Cited by 48
“AJP-Cell Physiol • doi:10.1152/ajpcell.00161.2012 • www.ajpcell.org MYPT1 contains many serine and threonine phosphorylation sites, including Ser432, Ser445, Ser472, Ser473, Ser601, Ser668, Ser692, Ser695, Thr696, Ser852, Thr853, and Ser910 (62, 240, 266, 270, 274, 275).”
BackgroundInfluentialParker, R., Clifton-Bligh, R. J., & Molloy, M. P. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0938 · Cited by 47
“Phosphorylation of S445 by NUAK1 inhibits targeting of PP1 to myosin, suppressing phosphatase activity and maintaining phospho-myosin essential for the actin-cytoskeletal rearrangements required for cell migration (32).”
BackgroundInfluentialLocard‐Paulet, M., Lim, L., Veluscek, G., McMahon, K. M., Sinclair, J., van Weverwijk, A., Worboys, J. D., Yuan, Y., Isacke, C. M., & Jørgensen, C. (2016) · Science Signaling · doi:10.1126/scisignal.aac5820 · Cited by 47
“For example, although phosphorylation at Ser(445), Ser(472), and Ser(910) regulates the involvement of protein phosphatase 1 regulatory subunit 12A (MYPT1) in cell adhesion (34), we identified Ser(509) as an MYPT1 phosphorylation site that showed a significant decrease in phosphorylation during LM2-HUVEC coculture.”
BackgroundLkb1 regulates organogenesis and early oncogenesis along AMPK-dependent and -independent pathways
Lo, B., Strasser, G. A., Sagolla, M. S., Austin, C. D., Junttila, M. R., & Mellman, I. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201208080 · Cited by 46
“The SAD-A/B kinases and SIK1/2 kinases together with Lkb1 modulate neuronal polarization (Barnes et al., 2007) and anoikis (Cheng et al., 2009), and Lkb1-NUAK signaling controls a phosphatase complex that regulates myosin light chain and cell adhesion (Zagórska et al., 2010).”
The AMPK-related kinase SNARK regulates muscle mass and myocyte survival
Lessard, S. J., Rivas, D. A., So, K., Koh, H., Queiroz, A. L., Hirshman, M. F., Fielding, R. A., & Goodyear, L. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79197 · Cited by 46
“Interestingly, AMPK itself does not phosphorylate MYPT1 (41), indicating a distinct role for SNARK and NUAK1 in the regulation of cytoskeletal dynamics via the myosin phosphatase complex.”
BackgroundBerggreen, C., Henriksson, E., Jones, H. A., Morrice, N. A., & Göransson, O. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2012.05.001 · Cited by 44
Pasapera, A. M., Heissler, S. M., Eto, M., Nishimura, Y., Fischer, R. S., Thiam, H. R., & Waterman, C. M. (2022) · Current Biology · doi:10.1016/j.cub.2022.04.088 · Cited by 43
“A previous report suggested that isolated MARK2 promotes MYPT1 phosphorylation.(58) We isolated MARK2-GFP from transfected COS1 cells by immunoprecipitation and tested its ability to phosphorylate MYPT1 in vitro.”
BackgroundCourchet, V., Roberts, A. J., Meyer-Dilhet, G., del Carmine, P., Lewis, T. L., Polleux, F., & Courchet, J. (2018) · Nature Communications · doi:10.1038/s41467-018-06584-5 · Cited by 42
Calcium signalling links MYC to NUAK1
Monteverde, T., Tait-Mulder, J., Hedley, A., Knight, J. R. P., Sansom, O. J., & Murphy, D. J. (2017) · Oncogene · doi:10.1038/onc.2017.394 · Cited by 41
“Perturbation of NUAK1 has revealed a diverse array of phenotypes, pointing to roles for NUAK1 in regulating cell adhesion (2), directional migration (3, 4), neuronal axon branching (5), glycogen synthesis (6), replicative senescence (7), and TAU stabilization (8).”
The LKB1 complex-AMPK pathway: the tree that hides the forest
Sebbagh, M., Olschwang, S., Santoni, M.-J., & Borg, J. (2011) · Familial Cancer · doi:10.1007/s10689-011-9457-7 · Cited by 40
“Nevertheless, NUAK1 activated by LKB1 complex has been found recently to lead to similar effect on MYPT1 [ 88 ].”
BackgroundTransforming growth factor β (TGFβ) induces NUAK kinase expression to fine-tune its signaling output
Kolliopoulos, C., Raja, E., Razmara, M., Heldin, P., Heldin, C., Moustakas, A., & van der Heide, L. P. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004984 · Cited by 40
Jun, A., Zhang, B., Zhang, Z., Hu, H., & Dong, J. (2021) · Cancers · doi:10.3390/cancers13040917 · Cited by 39
“NUAK1, also known as ARK5, encodes for an AMPK-related serine/threonine protein kinase that functions in cell adhesion [87], migration [88,89], and cellular and organismal metabolism [90].”
BackgroundLkb1 Deletion Promotes Ectopic Lipid Accumulation in Muscle Progenitor Cells and Mature Muscles
Shan, T., Zhang, P., Bi, P., & Kuang, S. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24831 · Cited by 39
“…commonly known as liver kinase B1 (Lkb1), is reported as a master regulator of many cellular processes including energy metabolism (Nakada et al., 2010), cellular polarity (Amin et al., 2009; Granot et al., 2009), cell adhesion (Zagorska et al., 2010), and cell death (Karuman et al., 2001).”
BackgroundEscalona, E., Muñoz, M., Pincheira, R., Elorza, Á. A., & Castro, A. F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01123 · Cited by 37
“In association with its effect on cell migration, the cytosolic NUAK1 phosphorylates the myosin phosphatase targeting-1 (MYPT1), promoting cell detachment (12).”
BackgroundOrlandella, F. M., Mariniello, R. M., Mirabelli, P., Stefano, A. E. D., Iervolino, P. L. C., Lasorsa, V. A., Capasso, M., Giannatiempo, R., Rongo, M., Incoronato, M., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0884-9 · Cited by 36
Fritz, J. L., Collins, O. M., Saxena, P., Buensuceso, A. V., Valdés, Y. R., Francis, K. E., Brown, K. R., Larsen, B. G., Colwill, K., Gingras, A., et al. (2020) · Cancers · doi:10.3390/cancers12051250 · Cited by 36
“NUAK1 promotes epithelial-to-mesenchymal transition (EMT) in cancer and induces cell detachment by regulating the MYPT-PP1β complex [22,24,32].”
BackgroundDrosophila NUAK functions with Starvin/BAG3 in autophagic protein turnover
Brooks, D. S., Naeem, F., Stetsiv, M., Goetting, S. C., Bawa, S., Green, N., Clark, C. P., Bashirullah, A., & Geisbrecht, E. R. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1008700 · Cited by 35
The emerging role of AMP-activated protein kinase in cholestatic liver diseases
Li, X., Liu, R., Zhang, L., & Jiang, Z. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.09.002 · Cited by 34
Development and Therapeutic Potential of NUAKs Inhibitors
Faisal, M., Kim, J. H., Yoo, K. H., Roh, E. J., Hong, S. S., & Lee, S. H. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00533 · Cited by 34
Molecular mechanisms underlying the interaction of protein phosphatase-1c with ASPP proteins
Skene-Arnold, T. D., Luu, H. A., Uhrig, R. G., Wever, V. D., Nimick, M., Maynes, J. T., Fong, A., James, M. N. G., Trinkle‐Mulcahy, L., Moorhead, G. B. G., et al. (2012) · Biochemical Journal · doi:10.1042/bj20120506 · Cited by 34
LKB1: An emerging therapeutic target for cardiovascular diseases
Molaei, A., Molaei, E., Sadeghnia, H. R., Hayes, A. W., & Karimi, G. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120844 · Cited by 33
Banerjee, S., Zagórska, A., Deak, M., Campbell, D. G., Prescott, A. R., & Alessi, D. R. (2014) · Biochemical Journal · doi:10.1042/bj20140408 · Cited by 32
“Sakamototide substrate peptide [ALNRTSSDSALHRRR] was used for endogenous NUAK1 activity assay as described previously [6].”
InfluentialSelf-citationLKB1: Can We Target an Hidden Target? Focus on NSCLC
Ndembe, G., Intini, I., Perin, E., Marabese, M., Caiola, E., Mendogni, P., Rosso, L., Broggini, M., & Colombo, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.889826 · Cited by 32
“All these events are regulated by LKB1-AMPK-related protein pathways such as the LKB1-NUAK pathways involved in cell adhesion (147), the LKB1-MARKs (MAP/microtubule affinity-regulating kinases) pathway controlling cell polarization and microtubule organization (23, 148), the LKB1-SRC/FAK (focal adhesion kinase) protei…”
BackgroundLKB1 signalling attenuates early events of adipogenesis and responds to adipogenic cues
Gormand, A., Berggreen, C., Amar, L., Henriksson, E., Lund, I., Albinsson, S., & Göransson, O. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0296 · Cited by 32
“2012) and the Sakamototide (ALNRTSSDSALHRRR) for SIK3 (Zagorska et al. 2010) was measured with 200 mM of the peptide substrates.”
MethodNUAK1 and NUAK2 Fine-Tune TGF-β Signaling
van de Vis, R. A. J., Moustakas, A., & van der Heide, L. P. (2021) · Cancers · doi:10.3390/cancers13133377 · Cited by 31
“Phosphorylation causes the inhibition of the phosphatase activity of PP1 MYPT1 , resulting in the phosphorylation of myosin regulatory light chain (MLC2), thereby stabilizing actin stress fibers and promoting cell detachment [18,40].”
LKB1 biology: assessing the therapeutic relevancy of LKB1 inhibitors
Trelford, C. B., & Shepherd, T. G. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01689-5 · Cited by 32
“3).”
Palma, M., Riffo, E. N., Suganuma, T., Washburn, M. P., Workman, J. L., Pincheira, R., & Castro, A. F. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28890 · Cited by 30
“On the other hand, one of the well‐ characterized cytoplasmic function of NUAK1 is the phosphorylation of myosin phosphatase targeting‐1 (MYPT1), which promotes cell detachment.(14) These studies indicate that NUAK1 resides in the nucleus and in the cytoplasm, suggesting some molecular mechanisms involved in NUAK1 sub…”
BackgroundMechanism and application of ferroptosis in colorectal cancer
Liu, Y., Zhang, Y., Zhang, Y., & Fan, Z. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.114102 · Cited by 28
miR-143 inhibits oncogenic traits by degrading NUAK2 in glioblastoma
FU, T.-G., Wang, L., Li, W., Li, J., & Li, J. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2562 · Cited by 28
“NUAK2, which resides at 1q32, is a member of the SNF1/AMPK family (serine/threonine kinases) that is regulated by the putative tumor suppressor, liver kinase B1 (LKB1; also known as serine/threonine kinase 11), as well as by death receptor signaling through nuclear factor (NF)- κ B (6,10-12).”
lncRNA FGD5‑AS1 promotes breast cancer progression by regulating the hsa‑miR‑195‑5p/NUAK2 axis
Fang, K., Xu, Z., Jiang, S., Tang, D., Yan, C., Deng, Y., & Zhao, F.-Y. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12099 · Cited by 27
“Correspondence to: Dr Fu‑Ying Zhao, Department of Gynecology, Yinchuan Maternal and Child Health Hospital, 56 Wenhua West Street, Yinchuan, Ningxia 750001, P.R. China E‑mail: 15209607043@163.com *Contributed equally Key words: lncRNA FGD5‑AS1, hsa‑miR‑195‑5p, SNF1‑like kinase 2, glycolysis, breast cancer SNF1‑like kin…”
RetractedLKB1 loss of function studied in vivo
Shorning, B. Y., & Clarke, A. R. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.01.019 · Cited by 27
“Furthermore, LKB1 has been shown to influence cell adhesion, cell death, detachment and invasion, for example though regulation of NUAK1 kinase activity, which is important for cytoskeletal motor protein regulation [8], and by regulation of SIK1-dependent anoikis [9].”
BackgroundLiver kinase B1 regulates the centrosome via PLK1
Werle, K. D., Chen, J., Xu, H.-G., Zhao, R.-X., He, Q., Lu, C., Cui, R., Liang, J., Li, Y.-L., & Xu, Z.-X. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.135 · Cited by 26
“Zagórska et al.18 recently reported that LKB1-activated NUAK1 interacts with and phosphorylates several myosin phosphatases, including MYPT1.”
InfluentialLanfranchi, M., Yandiev, S., Meyer-Dilhet, G., Ellouze, S., Kerkhofs, M., Dos Reis, R., Garcia, A., Blondet, C., Amar, A., Kneppers, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46146-6 · Cited by 25
“Although the cellular functions of NUAK1 are not fullyunderstood,itislinkedtothecontroloftheProteinPhosphatase1 activity through the regulation of regulatorysubunits, such as MYPT1 18 to regulate actomyosin contractility, or PNUTS 19 , linking NUAK1 to spliceosome assembly and RNA elongation.”
Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancer
Tang, Y. C., Ho, S.-C., Tan, E. L. S., Ng, A. W. T., McPherson, J. R., Goh, G. Y. L., Teh, B. T., Bard, F., & Rozen, S. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0949-3 · Cited by 25
The role of STK11/LKB1 in cancer biology: implications for ovarian tumorigenesis and progression
Kang, J., Gallucci, S., Pan, J., Oakhill, J. S., & Sanij, E. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1449543 · Cited by 24
Ussery, E. J., Nielsen, K. M., Simmons, D. B. D., Pandelides, Z., Mansfield, C., & Holdway, D. A. (2021) · Aquatic Toxicology · doi:10.1016/j.aquatox.2021.105761 · Cited by 24
Stroehlein, A. J., Young, N. D., Korhonen, P. K., Jabbar, A., Hofmann, A., Sternberg, P. W., & Gasser, R. B. (2015) · Parasites & Vectors · doi:10.1186/s13071-015-1231-5 · Cited by 23
“In addition, kinases of the NuaK family are involved in cell adhesion [69], and an expansion of this family might compensate for the reduction of the somewhat smaller FER family in H.”
BackgroundLi, Y., Song, X., Liu, L., & Yue, L. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12457 · Cited by 22
Role of ARK5 in cancer and other diseases (Review)
Mo, G., Zhang, B., & Jiang, Q. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10129 · Cited by 21
NUAK: never underestimate a kinase
Skalka, G., Whyte, D., Lubawska, D., & Murphy, D. J. (2024) · Essays in Biochemistry · doi:10.1042/ebc20240005 · Cited by 20
Posttranslational regulation of liver kinase B1 in human cancer
Hu, L., Liu, M., Tang, B., Li, Q., Pan, B., Xu, C. S., & Lin, H. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104570 · Cited by 19
Whyte, D., Skalka, G., Walsh, P. J., Wilczynska, A., Paul, N. R., Mitchell, C. A., Nixon, C., Clarke, W., Bushell, M., Morton, J. P., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13425 · Cited by 18
NUAK1 coordinates growth factor-dependent activation of mTORC2 and Akt signaling
Palma, M., Riffo, E. N., Farías, A., Coliboro-Dannich, V., Espinoza-Francine, L., Escalona, E., Amigo, R., Gutiérrez, J. L., Pincheira, R., & Castro, A. F. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01185-2 · Cited by 18
Metadata
- Authors
- Zagórska, A., Deak, M., Campbell, D. G., Banerjee, S., Hirano, M., Aizawa, S., Prescott, A. R., & Alessi, D. R.
- Affiliations
- University of Dundee (GB)
- MRC Protein Phosphorylation Unit, College of Life Sciences, University of Dundee, Dow Street, Dundee DD1 5EH, Scotland, UK.
- RIKEN (JP)
- Corresponding author
- Zagórska, Anna
- Alessi, Dario R.
- Venue
- Science Signaling
- Published
- 2010-03-30
- Volume
- 3
- Issue
- 115
- Pages
- ra25-ra25
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- OpenAlex
- W1963562375
- Cited by
- 193
- References
- 54
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 15 · 2023: 13 · 2022: 13 · 2021: 12 · 2020: 14 · 2019: 9 · 2018: 11 · 2017: 7 · 2016: 7 · 2015: 8 · 2014: 11 · 2013: 14 · 2012: 23
- FWCI
- 7.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- LKB1, NUAK1, NUAK2, myosin phosphatase, MYPT1, 14-3-3 proteins, cell adhesion, cell detachment, myosin light chain phosphorylation, AMPK-related kinases, protein phosphorylation, tumor suppressor
- MeSH terms
- AMP-Activated Protein Kinase Kinases, Cell Adhesion, Cell Line, Humans, Phosphorylation, Protein Binding, Protein Kinases, Recombinant Proteins, Repressor Proteins, Protein Serine-Threonine Kinases, Myosin Light Chains, Protein Isoforms, Amino Acid Motifs, Cardiac Myosins, Myosin-Light-Chain Phosphatase, 14-3-3 Proteins, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.